Xiaoling Wang
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Metformin versus DPP-4 inhibitors and risk of parkinsonism in type 2 diabetes: an active-comparator cohort study with a landmark design.
Journal: Diabetology & metabolic syndrome
Published: April 21, 2026
Prelimbic cortex layer 5 GABAergic neurons mediate chronic pain and memory impairment by regulating excitatory/inhibitory imbalance.
Journal: The journal of headache and pain
Published: March 26, 2026
GLP-1RAs versus metformin and Parkinson's risk in type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: November 28, 2025
Metformin use and reduced dementia risk in older adults with type 2 diabetes and delirium.
Journal: European journal of pharmacology
Published: October 25, 2025
Delirium as a Precursor to Dementia in Elderly Type 2 Diabetes Mellitus Patients.
Journal: The Journal of clinical psychiatry
Published: August 06, 2025
SGLT2 inhibitors vs. metformin for Parkinson's disease risk reduction in type 2 diabetes.
Journal: Journal of Parkinson's disease
Published: July 17, 2025
Statin therapy on dementia in elderly type 2 diabetes patients with delirium.
Journal: Diabetology & metabolic syndrome
Published: July 06, 2025
Long-term delirium and survival outcomes in patients treated with GLP-1 receptor agonists versus metformin in type 2 diabetes: A population-based cohort study.
Journal: Diabetes, obesity & metabolism
Published: February 26, 2025
Last Updated: 09/26/2026